No Data
No Data
Earnings Preview: Cryoport to Report Financial Results Post-market on March 04
Investors Holding Back On Cryoport, Inc. (NASDAQ:CYRX)
CryoPort Analyst Ratings
Needham Maintains Cryoport(CYRX.US) With Buy Rating, Maintains Target Price $11
CryoPort's Promising Revenue Growth and Profitability Drive Saxon's Buy Rating
Cryoport's CRYOGENE To Provide State-Of-The-Art Biorepository Services To Moffitt Cancer Center Via Strategic Collaboration